Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 12, 2015

The effects of short-term high-intensity interval training vs. moderate-intensity continuous training on plasma levels of nesfatin-1 and inflammatory markers

  • Sajad Ahmadizad , Alireza Salimi Avansar , Khosrow Ebrahim , Mohsen Avandi and Mansour Ghasemikaram EMAIL logo

Abstract

Objectives: Exercise training is an effective method of weight management, and knowing about its influence on the hormones involved in the regulation of food intake and inflammation could be useful for body weight management. Therefore, the purpose of this study was to compare the effects of 6 weeks of high-intensity interval training (HIIT) and moderate-intensity continuous exercise training (MCT) on nesfatin-1, interleukin (IL)-6, and tumor necrosis factor alpha (TNF-α).

Design and methods: Thirty sedentary overweight men (Mean±SD; age, 25±1 years) were divided into three (n=10) body mass index-matched groups. The participants in the training groups performed either HIIT or MCT protocols 3 days per week for 6 weeks followed by a week of detraining.

Results: Plasma IL-6 and TNF-α did not significantly change after training, but nesfatin increased significantly only with HIIT compared with the control group (p<0.05). In addition, fasting glucose, insulin, and homeostasis model estimated insulin resistance (HOMA-IR), decreased significantly following both HIIT and MCT training (p<0.05). After a detraining period, the plasma nesfatin-1 did not return to pre-training levels in the HIIT group.

Conclusions: Both the HIIT and MCT groups had similar effects on inflammatory markers and insulin resistance in men who are overweight, but the HIIT seems to have better anorectic effects (as indicated by nesfatin) compared with MCT.


Corresponding author: Mansour Ghasemikaram, Faculty of Sport Sciences, Department of Sport and Exercise Physiology, University of Shahid Beheshti, Velenjak Square, Tehran, Iran, Postcode: 1983963113, Phone: +98-21-29902931, Fax: +98-21-22431953, E-mail:

References

1. Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443:709–12.10.1038/nature05162Search in Google Scholar PubMed

2. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010;151:3169–80.10.1210/en.2009-1358Search in Google Scholar PubMed

3. Stengel A, Goebel M, Wang L, Tache Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric x/a-like cells: role as regulators of food intake and body weight. Peptides 2010;31:357–69.10.1016/j.peptides.2009.11.019Search in Google Scholar PubMed PubMed Central

4. Nakata M, Manaka K, Yamamoto S, Mori M, Yada T. Nesfatin-1 enhances glucose-induced insulin secretion by promoting ca(2+) influx through l-type channels in mouse islet beta-cells. Endocr J 2011;58:305–13.10.1507/endocrj.K11E-056Search in Google Scholar

5. Foo KS, Brauner H, Ostenson CG, Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 2010;204:255–63.10.1677/JOE-09-0254Search in Google Scholar PubMed

6. Aydin S. Multi-functional peptide hormone nucb2/nesfatin-1. Endocrine 2013;44:312–25.10.1007/s12020-013-9923-0Search in Google Scholar PubMed

7. Shimizu H, Oh IS, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009;150:662–71.10.1210/en.2008-0598Search in Google Scholar PubMed

8. Wernecke K, Lamprecht I, Johren O, Lehnert H, Schulz C. Nesfatin-1 increases energy expenditure and reduces food intake in rats. Obesity (Silver Spring) 2014;22:1662–8.10.1002/oby.20736Search in Google Scholar PubMed

9. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh IS, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010;73:484–90.10.1111/j.1365-2265.2010.03835.xSearch in Google Scholar PubMed

10. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010;159:72–7.10.1016/j.regpep.2009.11.003Search in Google Scholar PubMed

11. Gonzalez R, Perry RL, Gao X, Gaidhu MP, Tsushima RG, Ceddia RB, Unniappan S. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011;152:3628–37.10.1210/en.2010-1471Search in Google Scholar PubMed

12. Su Y, Zhang J, Tang Y, Bi F, Liu JN. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 2010;391:1039–42.10.1016/j.bbrc.2009.12.014Search in Google Scholar PubMed

13. Zhang Z, Li L, Yang M, Liu H, Boden G, Yang G. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2012;120:91–5.10.1055/s-0031-1286339Search in Google Scholar PubMed

14. Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G. Nesfatin-1 action in the brain increases insulin sensitivity through akt/ampk/torc2 pathway in diet-induced insulin resistance. Diabetes 2012;61:1959–68.10.2337/db11-1755Search in Google Scholar PubMed PubMed Central

15. Shimizu H, Mori M. Nesfatin-1: its role in the diagnosis and treatment of obesity and some psychiatric disorders. Methods Mol Biol 2013;963:327–38.10.1007/978-1-62703-230-8_20Search in Google Scholar PubMed

16. Scotece M, Conde J, Abella V, Lopez V, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Nucb2/nesfatin-1: a new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study. J Orthop Res 2014;32:653–60.10.1002/jor.22585Search in Google Scholar PubMed

17. Ghanbari-Niaki A, Kraemer RR, Soltani R. Plasma nesfatin-1 and glucoregulatory hormone responses to two different anaerobic exercise sessions. Eur J Appl Physiol 2010;110:863–8.10.1007/s00421-010-1531-6Search in Google Scholar PubMed

18. Chaolu H, Asakawa A, Ushikai M, Li YX, Cheng KC, Li JB, Zoshiki T, Terashi M, Tanaka C, Atsuchi K, Sakoguchi T, Tsai M, Amitani H, Horiuchi M, Takeuchi T, Inui A. Effect of exercise and high-fat diet on plasma adiponectin and nesfatin levels in mice. Exp Ther Med 2011;2:369–73.10.3892/etm.2011.199Search in Google Scholar PubMed PubMed Central

19. Haghshenas R, Jafari M, Ravasi A, Kordi M, Gilani N, Shariatzadeh M, Hedayati M, Rahimi M. The effect of eight weeks endurance training and high-fat diet on appetite-regulating hormones in rat plasma. Iran J Basic Med Sci 2014;17:237–43.Search in Google Scholar

20. Earnest CP. Exercise interval training: an improved stimulus for improving the physiology of pre-diabetes. Med Hypotheses 2008;71:752–61.10.1016/j.mehy.2008.06.024Search in Google Scholar PubMed

21. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slørdahl SA, Kemi OJ, Najjar SM, Wisløff U. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008;118:346–54.10.1161/CIRCULATIONAHA.108.772822Search in Google Scholar PubMed PubMed Central

22. Whyte LJ, Gill JM, Cathcart AJ. Effect of 2 weeks of sprint interval training on health-related outcomes in sedentary overweight/obese men. Metabolism 2010;59:1421–8.10.1016/j.metabol.2010.01.002Search in Google Scholar PubMed

23. Barker AR, Day J, Smith A, Bond B, Williams CA. The influence of 2 weeks of low-volume high-intensity interval training on health outcomes in adolescent boys. J Sports Sci 2014;32:757–65.10.1080/02640414.2013.853132Search in Google Scholar PubMed

24. Boutcher SH. High-intensity intermittent exercise and fat loss. J Obes 2011;2011:868305.10.1155/2011/868305Search in Google Scholar PubMed PubMed Central

25. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American college of sports medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41:459–71.10.1249/MSS.0b013e3181949333Search in Google Scholar PubMed

26. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007;115:3086–94.10.1161/CIRCULATIONAHA.106.675041Search in Google Scholar PubMed

27. Helgerud J, Hoydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, Simonsen T, Helgesen C, Hjorth N, Bach R, Hoff J. Aerobic high-intensity intervals improve vo2max more than moderate training. Med Sci Sports Exerc 2007;39:665–71.10.1249/mss.0b013e3180304570Search in Google Scholar PubMed

28. Zwetsloot KA, John CS, Lawrence MM, Battista RA, Shanely RA. High-intensity interval training induces a modest systemic inflammatory response in active, young men. J Inflamm Res 2014;7:9–17.10.2147/JIR.S54721Search in Google Scholar PubMed PubMed Central

29. Hazell TJ, Olver TD, Hamilton CD, Lemon PW. Two minutes of sprint-interval exercise elicits 24-hr oxygen consumption similar to that of 30 min of continuous endurance exercise. Int J Sport Nutr Exerc Metab 2012;22:276–83.10.1123/ijsnem.22.4.276Search in Google Scholar PubMed

30. Huang H, Iida KT, Sone H, Yokoo T, Yamada N, Ajisaka R. The effect of exercise training on adiponectin receptor expression in kkay obese/diabetic mice. J Endocrinol 2006;189:643–53.10.1677/joe.1.06630Search in Google Scholar PubMed

31. Moghadasi M, Mohebbi H, Rahmani-Nia F, Hassan-Nia S, Noroozi H, Pirooznia N. High-intensity endurance training improves adiponectin mrna and plasma concentrations. Eur J Appl Physiol 2012;112:1207–14.10.1007/s00421-011-2073-2Search in Google Scholar PubMed

32. Cha SH, Lane MD. Central lactate metabolism suppresses food intake via the hypothalamic amp kinase/malonyl-coa signaling pathway. Biochem Biophys Res Commun 2009;386:212–6.10.1016/j.bbrc.2009.06.017Search in Google Scholar PubMed

33. Nikseresht M, Sadeghifard N, Agha-Alinejad H, Ebrahim K. Inflammatory markers and adipocytokine responses to exercise training and detraining in men who are obese. J Strength Cond Res 2014;28:3399–410.10.1519/JSC.0000000000000553Search in Google Scholar PubMed

34. Croft L, Bartlett JD, MacLaren DP, Reilly T, Evans L, Mattey DL, Nixon NB, Drust B, Morton JP. High-intensity interval training attenuates the exercise-induced increase in plasma il-6 in response to acute exercise. Appl Physiol Nutr Metab 2009;34:1098–107.10.1139/H09-117Search in Google Scholar PubMed

35. Reihmane D, Dela F. Interleukin-6: possible biological roles during exercise. Eur J Sport Sci 2014;14:242–50.10.1080/17461391.2013.776640Search in Google Scholar PubMed

36. Tonoli C, Heyman E, Roelands B, Buyse L, Cheung SS, Berthoin S, Meeusen R. Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. Sports Med 2012;42:1059–80.10.1007/BF03262312Search in Google Scholar PubMed

37. Ahmadizad S, Ghorbani S, Ghasemikaram M, Bahmanzadeh M. Effects of short-term nonperiodized, linear periodized and daily undulating periodized resistance training on plasma adiponectin, leptin and insulin resistance. Clinical biochemistry 2014;47:417–22.10.1016/j.clinbiochem.2013.12.019Search in Google Scholar PubMed

38. Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama K, Amitani M, Harada T, Yasuhara D, Inui A. Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 2011;32:150–3.10.1016/j.peptides.2010.10.004Search in Google Scholar PubMed

39. Aslan M, Celik O, Celik N, Turkcuoglu I, Yilmaz E, Karaer A, Simsek Y, Celik E, Aydin S. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2012;41: 424–9.10.1007/s12020-011-9577-8Search in Google Scholar PubMed

40. Bajpeyi S, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Hickner RC, Kraus WE, Houmard JA. Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. J Appl Physiol (1985) 2009;106:1079–85.10.1152/japplphysiol.91262.2008Search in Google Scholar PubMed PubMed Central

Received: 2014-11-6
Accepted: 2014-12-8
Published Online: 2015-1-12
Published in Print: 2015-3-1

©2015 by De Gruyter

Downloaded on 19.5.2024 from https://www.degruyter.com/document/doi/10.1515/hmbci-2014-0038/html
Scroll to top button